Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.
Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Mooney J, Sargeant C, Braaten J, Bernard T, King D, Miceli E, Schmoll J, Hoskin T, Thapa P, Enders F. Lindor KD, et al. Among authors: befeler as. Hepatology. 2009 Sep;50(3):808-14. doi: 10.1002/hep.23082. Hepatology. 2009. PMID: 19585548 Free PMC article. Clinical Trial.
Outcomes of kidney, liver, and simultaneous liver and kidney transplants from hepatitis c infected donors to hepatitis c naïve recipients: A large single center experience.
Elbeshbeshy H, Modi N, Patel T, Matthews I, Kampert T, Lee J, Okeke R, Caliskan Y, Fleetwood V, Varma C, Gabris B, Bastani B, Abu Al Rub F, Guenette A, Befeler A, Agbim U, Desai R, Alsabbagh E, Qureshi K, Schnitzler M, Lentine KL, Randall HB, Nazzal M. Elbeshbeshy H, et al. Clin Transplant. 2024 Jan;38(1):e15161. doi: 10.1111/ctr.15161. Epub 2023 Oct 16. Clin Transplant. 2024. PMID: 37842872
The predictors of the presence of varices in patients with primary sclerosing cholangitis.
Treeprasertsuk S, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Schmoll J, Hoskin T, Thapa P, Enders F, Lindor KD. Treeprasertsuk S, et al. Among authors: befeler as. Hepatology. 2010 Apr;51(4):1302-10. doi: 10.1002/hep.23432. Hepatology. 2010. PMID: 20044810 Free PMC article. Clinical Trial.
High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Eaton JE, Silveira MG, Pardi DS, Sinakos E, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Lindor KD. Eaton JE, et al. Among authors: befeler as. Am J Gastroenterol. 2011 Sep;106(9):1638-45. doi: 10.1038/ajg.2011.156. Epub 2011 May 10. Am J Gastroenterol. 2011. PMID: 21556038 Free PMC article. Clinical Trial.
High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis.
Imam MH, Sinakos E, Gossard AA, Kowdley KV, Luketic VA, Edwyn Harrison M, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, DeCook AC, Enders F, Lindor KD. Imam MH, et al. Among authors: befeler as. Aliment Pharmacol Ther. 2011 Nov;34(10):1185-92. doi: 10.1111/j.1365-2036.2011.04863.x. Epub 2011 Sep 29. Aliment Pharmacol Ther. 2011. PMID: 21957881 Free PMC article.
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.
Yang JD, Dai J, Singal AG, Gopal P, Addissie BD, Nguyen MH, Befeler AS, Reddy KR, Schwartz M, Harnois DM, Yamada H, Gores GJ, Feng Z, Marrero JA, Roberts LR. Yang JD, et al. Among authors: befeler as. Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):1085-1092. doi: 10.1158/1055-9965.EPI-16-0747. Epub 2017 Mar 3. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28258053 Free PMC article.
47 results